Chairman
BeOne Medicines Ltd. (ONC)Equibles does not estimate personal net worth.
Get an email with a short summary when BeOne Medicines Ltd. publishes a filing, an earnings call transcript or a press release.
Get ONC alertsJohn V. Oyler is recorded as Chairman at BeOne Medicines Ltd. (ONC) since June 11, 2026. BeOne Medicines Ltd. reported in an 8-K filed June 11, 2026 that John V. Oyler was appointed Chairman of the Board of Directors, effective June 11, 2026. John V. Oyler has spoken on 1 investor event across 1 company, most recently for BeOne Medicines Ltd. on September 14, 2026. BeOne Medicines Ltd. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at BeOne Medicines Ltd. includes Mr. John V. Oyler (CEO and Board Member), Mr. Aaron Rosenberg (CFO), Dr. Xiaobin Wu (COO) and 7 others.
“Mr. John V. Oyler was re-elected to serve as Chairman of the Board of Directors.”
“I think if you step back, it's worth reminding everyone how we develop the molecule and design the molecule. The molecule was designed to be the most potent against CDK4 in the class and also the most selective.”
2026-06-11–present
2010-01-01–2024-04-26
Last confirmed by a filing; no departure on record
Start not stated–2025-04-07
Last confirmed by a filing; no departure on record
Biotechnology · Healthcare
Chairman
2010-01-01–present
